Latest Capital Raising News

Oceana Lithium Limited has successfully raised $667,000 through a discounted share placement, attracting strong support from institutional and high-net-worth investors. The funds will accelerate exploration and development across its Australian and Brazilian lithium assets.

Macarthur Minerals has secured $250,000 through unsecured convertible notes to bolster its working capital and support ongoing operations amid challenging market conditions.

Yowie Group Ltd has firmly rejected the validity of director removal and nomination notices purportedly from Keybridge Capital, while confirming its status as Keybridge’s largest creditor with over $6.6 million owed. The company also detailed a recent share placement amid ongoing regulatory scrutiny.

F.F.I. Holdings has corrected its earlier statement, confirming its $11 million entitlement offer at $3.50 per share is not underwritten. The offer aims to fund property development and debt reduction, with directors backing the raise.

Nanollose has successfully placed the $1.05 million shortfall from its recent entitlement offer, bolstering its capital to advance production and commercialisation of its innovative biomaterials.

Sunstone Metals Ltd has had its trading suspension lifted following a Federal Court decision and the release of a cleansing prospectus, signaling a fresh chapter for the mining company on the ASX.

Terrain Minerals has kicked off a 3,350-meter drilling campaign at its Lightning and Monza prospects, aiming to expand on recent high-grade gold and silver discoveries. Concurrently, the company has opened a $1.8 million rights issue to fund ongoing exploration and development.

Elixinol Wellness Limited reported a robust FY24 performance, achieving an 81% increase in revenue and significantly narrowing its losses. The company is now focused on scaling its direct-to-consumer channels and operational efficiencies to reach profitability in 2025.

Chimeric Therapeutics has raised $6.6 million through a discounted two-tranche placement to accelerate its promising CAR-T and NK cell therapy clinical programs. The capital raise, strongly backed by institutional and professional investors, signals growing confidence in the company’s oncology pipeline.

Atomo Diagnostics has released a Target Market Determination for a new capital raising involving options and shares, including a $1 million Share Purchase Plan and placement offer. The move targets eligible Australian shareholders and aims to bolster the company’s financial position amid a speculative investment environment.

Atomo Diagnostics Limited has announced a capital raising initiative comprising a Share Purchase Plan (SPP) and a Placement, aiming to raise up to $1 million through the SPP and additional funds via a Placement, subject to shareholder approval at a June 23 meeting.

Andromeda Metals has successfully raised $5 million through a share placement to institutional investors, aiming to accelerate development of its Great White and HPA projects. The company also plans to issue options that could inject further capital if exercised.